154 related articles for article (PubMed ID: 17868457)
1. Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells.
Shelby BD; LaMarca HL; McFerrin HE; Nelson AB; Lasky JA; Sun G; Myatt L; Offermann MK; Morris CA; Sullivan DE
Virol J; 2007 Sep; 4():87. PubMed ID: 17868457
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
3. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
4. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
5. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
[TBL] [Abstract][Full Text] [Related]
8. Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.
George Paul A; Sharma-Walia N; Kerur N; White C; Chandran B
Cancer Res; 2010 May; 70(9):3697-708. PubMed ID: 20388794
[TBL] [Abstract][Full Text] [Related]
9. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.
Cannon M; Philpott NJ; Cesarman E
J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
[TBL] [Abstract][Full Text] [Related]
12. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
Sadagopan S; Sharma-Walia N; Veettil MV; Bottero V; Levine R; Vart RJ; Chandran B
J Virol; 2009 Apr; 83(7):3342-64. PubMed ID: 19158252
[TBL] [Abstract][Full Text] [Related]
14. The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells.
Bakken T; He M; Cannon ML
Virology; 2010 Feb; 397(2):379-88. PubMed ID: 20004456
[TBL] [Abstract][Full Text] [Related]
15. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection.
Gjyshi O; Bottero V; Veettil MV; Dutta S; Singh VV; Chikoti L; Chandran B
PLoS Pathog; 2014 Oct; 10(10):e1004460. PubMed ID: 25340789
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat.
Pati S; Foulke JS; Barabitskaya O; Kim J; Nair BC; Hone D; Smart J; Feldman RA; Reitz M
J Virol; 2003 May; 77(10):5759-73. PubMed ID: 12719569
[TBL] [Abstract][Full Text] [Related]
18. Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor.
Choi YB; Nicholas J
Virology; 2010 Feb; 397(2):369-78. PubMed ID: 20004457
[TBL] [Abstract][Full Text] [Related]
19. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
[TBL] [Abstract][Full Text] [Related]
20. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma.
Jensen KK; Manfra DJ; Grisotto MG; Martin AP; Vassileva G; Kelley K; Schwartz TW; Lira SA
J Immunol; 2005 Mar; 174(6):3686-94. PubMed ID: 15749907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
